{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:40:09Z","timestamp":1788964809973,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Hebei Natural Science Foundation","award":["H2018206066"],"award-info":[{"award-number":["H2018206066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-019-1137-9","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T14:37:03Z","timestamp":1561387023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention"],"prefix":"10.1186","volume":"19","author":[{"given":"Guoqiang","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuechao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2594-576X","authenticated-orcid":false,"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"1137_CR1","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/j.1442-2042.2011.02830.x","volume":"18","author":"K Kitajima","year":"2011","unstructured":"Kitajima K, Maeda T, Watanabe S, Sugimura K. Recent issues in contrast-induced nephropathy. Int J Urol. 2011;18:686\u201390.","journal-title":"Int J Urol"},{"key":"1137_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4037\/ccn2013680","volume":"33","author":"AL Jorgensen","year":"2013","unstructured":"Jorgensen AL. Contrast-induced nephropathy: pathophysiology and preventive strategies. Crit Care Nurse. 2013;33:37\u201346.","journal-title":"Crit Care Nurse"},{"key":"1137_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.avsg.2015.10.017","volume":"32","author":"C Koch","year":"2016","unstructured":"Koch C, Chaudru S, Lederlin M, Jaquinandi V, Kaladji A, Mahe G. Remote ischemic preconditioning and contrast-induced nephropathy: a systematic review. Ann Vasc Surg. 2016;32:176\u201387.","journal-title":"Ann Vasc Surg"},{"key":"1137_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3111\/200710119134","volume":"10","author":"S Subramanian","year":"2007","unstructured":"Subramanian S, Tumlin J, Bapat B, Zyczynski T. Economic burden of contrast-induced nephropathy: implications for prevention strategies. J Med Econ. 2007;10:119\u201334.","journal-title":"J Med Econ"},{"key":"1137_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jcrc.2011.05.010","volume":"26","author":"K Lakhal","year":"2011","unstructured":"Lakhal K, Ehrmann S, Chaari A, Laissy JP, Regnier B, Wolff M, et al. Acute kidney injury network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care. 2011;26:593\u20139.","journal-title":"J Crit Care"},{"key":"1137_CR6","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1137_CR7","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.amjcard.2016.03.033","volume":"117","author":"YH Liu","year":"2016","unstructured":"Liu YH, Liu Y, Zhou YL, He PC, Yu DQ, Li LW, et al. Comparison of different risk scores for predicting contrast induced nephropathy and outcomes after primary percutaneous coronary intervention in patients with ST elevation myocardial infarction. Am J Cardiol. 2016;117:1896\u2013903.","journal-title":"Am J Cardiol"},{"key":"1137_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3810\/pgm.2011.01.2252","volume":"123","author":"EB Windgassen","year":"2011","unstructured":"Windgassen EB, Funtowicz L, Lunsford TN, Harris LA, Mulvagh SL. C-reactive protein and high-sensitivity C-reactive protein: an update for clinicians. Postgrad Med. 2011;123:114\u20139.","journal-title":"Postgrad Med"},{"key":"1137_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000329534","volume":"34","author":"F Gao","year":"2011","unstructured":"Gao F, Zhou YJ, Zhu X, Wang ZJ, Yang SW, Shen H. C-reactive protein and the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Am J Nephrol. 2011;34:203\u201310.","journal-title":"Am J Nephrol"},{"issue":"Suppl 1","key":"1137_CR10","first-page":"S57","volume":"49","author":"P Maruna","year":"2000","unstructured":"Maruna P, Nedelnikova K, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49(Suppl 1):S57\u201361.","journal-title":"Physiol Res"},{"key":"1137_CR11","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ijid.2007.09.007","volume":"12","author":"P Indino","year":"2008","unstructured":"Indino P, Lemarchand P, Bady P, de Torrente A, Genne L, Genne D. Prospective study on procalcitonin and other systemic infection markers in patients with leukocytosis. Int J Infect Dis. 2008;12:319\u201324.","journal-title":"Int J Infect Dis"},{"key":"1137_CR12","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1177\/0003319715572218","volume":"66","author":"A Kurtul","year":"2015","unstructured":"Kurtul A, Murat SN, Yarlioglues M, Duran M, Ocek AH, Celik IE, et al. Procalcitonin as an early predictor of contrast-induced acute kidney injury in patients with acute coronary syndromes who underwent percutaneous coronary intervention. Angiology. 2015;66:957\u201363.","journal-title":"Angiology"},{"key":"1137_CR13","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1161\/CIRCULATIONAHA.106.671644","volume":"115","author":"RJ Solomon","year":"2007","unstructured":"Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, et al. Cardiac angiography in Renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007;115:3189\u201396.","journal-title":"Circulation"},{"key":"1137_CR14","doi-asserted-by":"publisher","first-page":"332","DOI":"10.5301\/jn.5000007","volume":"25","author":"Y Liu","year":"2012","unstructured":"Liu Y, Tan N, Zhou YL, Chen YY, Chen JY, Chen J, et al. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention. J Nephrol. 2012;25:332\u201340.","journal-title":"J Nephrol"},{"key":"1137_CR15","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1172\/JCI200215606","volume":"110","author":"G Ramesh","year":"2002","unstructured":"Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002;110:835\u201342.","journal-title":"J Clin Invest"},{"key":"1137_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000346528","volume":"37","author":"CF Chang","year":"2013","unstructured":"Chang CF, Lu TM, Yang WC, Lin SJ, Lin CC, Chung MY. Gene polymorphisms of interleukin-10 and tumor necrosis factor-alpha are associated with contrast-induced nephropathy. Am J Nephrol. 2013;37:110\u20137.","journal-title":"Am J Nephrol"},{"key":"1137_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000049032","volume":"90","author":"MD Okusa","year":"2002","unstructured":"Okusa MD. The inflammatory cascade in acute ischemic renal failure. Nephron. 2002;90:133\u20138.","journal-title":"Nephron"},{"key":"1137_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/head.12301","volume":"54","author":"AC Raddant","year":"2014","unstructured":"Raddant AC, Russo AF. Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia. Headache. 2014;54:472\u201384.","journal-title":"Headache"},{"key":"1137_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/heartjnl-2017-311975","volume":"104","author":"J Silvain","year":"2018","unstructured":"Silvain J, Nguyen LS, Spagnoli V, Kerneis M, Guedeney P, Vignolles N, et al. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart. 2018;104:767\u201372.","journal-title":"Heart"},{"key":"1137_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10557-017-6766-6","volume":"32","author":"E Kaltsas","year":"2018","unstructured":"Kaltsas E, Chalikias G, Tziakas D. The incidence and the prognostic impact of acute kidney injury in acute myocardial infarction patients: current preventive strategies. Cardiovasc Drugs Ther. 2018;32:81\u201398.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1137_CR21","doi-asserted-by":"crossref","unstructured":"Schmucker J, Fach A, Becker M, Seide S, Bunger S, Zabrocki R et al. Predictors of acute kidney injury in patients admitted with ST-elevation myocardial infarction - results from the Bremen STEMI-registry. Eur Heart J Acute Cardiovasc Care 2017:2048872617708975.","DOI":"10.1177\/2048872617708975"},{"key":"1137_CR22","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcin.2016.11.006","volume":"10","author":"A Putzu","year":"2017","unstructured":"Putzu A, Boscolo Berto M, Belletti A, Pasotti E, Cassina T, Moccetti T, et al. Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures. A Systematic Review and Meta-Analysis of Randomized Trials JACC Cardiovasc Interv. 2017;10:355\u201363.","journal-title":"A Systematic Review and Meta-Analysis of Randomized Trials JACC Cardiovasc Interv"},{"key":"1137_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000350648","volume":"125","author":"GQ Gu","year":"2013","unstructured":"Gu GQ, Lu R, Cui W, Liu F, Zhang Y, Yang XH, et al. Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography. Cardiology. 2013;125:69\u201373.","journal-title":"Cardiology"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1137-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-019-1137-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-019-1137-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T23:15:04Z","timestamp":1592867704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-019-1137-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1137"],"URL":"https:\/\/doi.org\/10.1186\/s12872-019-1137-9","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"29 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee of Second Hospital of Hebei Medical University approved this prospective study. Written informed consent was obtained from all individual participants included in the study. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}